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Summary.-Animals treated with a sufficiently high dose of busulphan die about 14
days later from bone marrow failure. A single, appropriately timed injection of
cyclophosphamide can save these mice. The nature of this protection is shown to be
the cyclophosphamide induced elaboration of a humoral factor which stimulates
haemopoietic recovery.
THE USE of cytotoxic agents in cancer
chemotherapy is often limited by the
action of these agents on the normal,
homoeostatic, proliferating cells of the
body, particularly those of the bone
marrow. Any substance which enhances
haemopoietic recovery, particularly during
bone marrow depression induced by cyto-
toxic agents, is of importance.
Cyclophosphamide, in addition to
having a cytotoxic effect on the pro-
liferating haemopoietic cells of the bone
marrow, appears also to enhance subse-
quent recovery of these cells (Gregory
et al., 1971; Fried et al., 1973). Evidence
that a long-range diffusible substance is
involved in this stimulation was pre-
sented by Stohlman et al. (1973). These
authors observed enhanced growth of
bone marrow in diffusion chambers im-
planted in cyclophosphamide treated
hosts.
The timing of the administration of
cyclophosphamide is important in relation
to the transplantation ofthe bone marrow
(Gregory et al., 1971; Fried et al., 1973) the
cyclophosphamide being given between 1
and 4 days before the transplantation for
optimum stimulation. Gregory et al.
(1971) have suggested that the cyclo-
phosphamide may cause the elaboration of
a substance as a result of cell damage
which stimulates haemopoietic stem cell
recovery. Dons et al. (1974) have shown
that factor(s) present in spleen extract and
14
fetuin, a foetal protein, cause regeneration
ofthe haemopoietic stem cells inirradiated
mice.
In this communication direct evidence
is presented that haemopoiesis is enhanced
by a humoral factor elaborated after
cyclophosphamide administration. It is
demonstrated that this serum factor is
transferable and can prevent the death of
otherwise lethally treated animals.
MATERIALS AND METHODS
Animals.-Male or female, 9-10 week old,
CBA mice were used in all experiments. The
female mice, weighing between 18 and 23 g
acted as recipients of bone marrow in spleen
colony experiments. The male mice,
weighing between 22 and 27 g, were used in
all other experiments. Both male and female
mice were used to obtain serum.
Drugs.-Cyclophosphamide (Endoxana,
Ward Blenkinsop & Co.) was dissolved in
water for injection, whereas the busulphan
(Burroughs Wellcome & Co.) was first
dissolved in dimethyl sulphoxide to form a
0.05% (w/v) solution, which was then
emulsified in arachis oil in the ratio of9 parts
arachis oil to 1 part solution. Both drugs
were injected intraperitoneally.
CFU assay.-The CFU content of femurs
was assayed using the method of Till and
McCulloch (1961). Recipient mice were
given 850 rad 60Co y irradiation 4 h before
bone marrow transplantation. Groups
varied in size from 8 to 14 mice.
Granulocyte count.-The blood leucocyte
concentration was measured using a model FJ. L. MILLAR, B. N. HUDSPITH AND N. M. BLACKETT
Coulter counter and differentials performed
on ethanol fixed, Giemsa stained blood films
made at the time of sampling. A hundred
cells per slide were analysed.
Serum-.Mice were given 200 mg/kg
cyclophosphamide and 2 days later bled from
the axilla. The blood was allowed to clot
overnight at 4°C. After centrifugation the
serum was removed, passed through a
0 22 jtm Millipore filter and dialysed in 8/32
Visking tubing against distilled water for 3
days at 4°C. The water, which contained
250,000 u of both penicillin and streptomycin
per litre, was changed twice during the
dialysis. The product was centrifuged to
remove the precipitate, which was re-
suspended in isotonic saline to its original
concentration. Test sera were injected intra-
peritoneally in 0*5 ml aliquots daily for three
days following the busulphan.
RESULTS
Effect of the combination of cyclophospha-
mide and busulphan on theprimary animal
Animal sarvival.- Cyclophosphamide
(200 mg/kg) was given to animals lethally
treated with busulphan (35 mg/kg or
45 mg/kg) at different times before or
after the busulphan (Table la). These
doses ofbusulphan result in the death ofat
least 90%/ of the treated animals in 30
days but the dose of cyclophosphamide
used has never produced any deaths over
the 30-day period investigated. The
survival of animals that received the
lethal dose of busulphan as well as the
cyclophosphamide improved dramatically
when the cyclophosphamide was injected
one or 2 days before the busulphan. At
other times the survival was less, but
generally better than that of animais
receiving no cyclophosphamide. Table lb
indicates that the spleen does not play a
major role in this effect. Using the
optimum timing and order of administra-
tion of the drugs, it was shown that the
considerable sparing effect seen in Table la
could be obtained in animals recently
splenectomized or splenectomized for some
time compared with similar animals
receiving busulphan alone.
Effect on blood granulocyte concezi-
tration. The effect of cyclophosphamide
(200 mg/kg), busulphan (30 mg/kg) and a
combination of the two drugs on the time
course of blood granulocyte concentration
is shown in the Figure. The combination,
cyclophosphamide given 48 h before
busulphan, is that which gives the best
survival as judged by Table la.
A reduced dose of busulphan (30 mg/
kg) was used to allow 21-day survival in
groups of animals given busulphan alone.
An animal receiving this drug alone
initially maintains a high blood granulo-
cyte concentration (Figure); the granu-
locyte concentration then falls, there is an
abortive recovery Day 7 to 9 and finally it
reaches its lowest value after 14 days when
I TABLE Ia. Effect ofPre- or Post Treatment with (,.tyclophosphamide (200 mg/kg)
on the 30-day Survival of Animals Lethally Treated with Busulphan (35mg/kg
or 45 mg/kg)
Time ofcyclophosphami(ie
injection in relation to
busulphan
4 (lays before
3 (tays befoIe
2 days before
1 (lay before
same day
1 (lay after
2 days after
3 days after
4 days after
Busulphan only controls
Animals receiving
cyclophosphamide only
30-day survival
after 35 mg/kg Bi
1/14 70/O
13/14 93%
12/14 86%
10/14 71o%
10/14 710%
5/14 360%
0/14 0%
30-day survival
afteI 45 mg/kg Bi
0/15 0%
0/14 0%
6/14 43%
9/14 640
5/14 36;O/
4/14 29%0
2/14 14%
1/14 7%
2/14 14%
0/14 000
Average day of death
of non-survivors
m S.E.
11 9+0 4
12-9+1 1
21* 9± 1I 5
17 - 7 2 - 2
I 15±2-4
I 3 6 I 1
12-82I-0
14 - 2 + 1* 6
14-2 0- 6
15-8±0-9
14/14 10000 14/14 100%
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TABLE lb. Effect of Splenectomy on the Enhanced Survival of Animals
Given Cy (200 mg/kg) One Day Before a Lethal Dose of Bu (45 mg/kg)
Animals splenectomized
5 months before treatment
2 weeks before treatment
30o r
30-day survival after Cy (200 mg/kg)
Iday before Bu (45 mg/kg)
3/5 6000
5/9 560
I
30-day survival after Bu
alone (45 mg/kg)
0/5 00
1/8 1i3
T T
.oo0
II
W~~~~~1 IVl
..
\o Bu 0-Bu
7 9 11 14 18 21
Day after BU
FIGURE. Recovery of peripheral granulocytes after treatment with 200 mg/kg cyclophosphamide
(Cy), 30 mg/kg busulphan (Bu) or both. Cy48Bu indicates that the cyclophosphamide was
injected 48 h before the busulphan. Note that the time scale refers to the busulphan injection.
the animal usually dies. In contrast, an
animal given cyclophosphamide alone
experiences a rapid initial fall in blood
granulocyte level followed by a very rapid
recovery from Day 4 to Day 7, after which
there is a period ofneutrophilia lasting 6-7
days. The blood granulocyte level in an
animal that received the drug combination
(cyclophosphamide 2 days before busul-
phan) behaves very similarly to the
cyclophosphamide alone situation, sug-
gesting that cyclophosphamide pretreat-
ment was rendering the busulphan
ineffective. For this reason, in all the
serum experiments to be described next
busulphan was administered 24 h before
the serum.
Experiments involving serum from cyclo-
phosphamide treated animals
Effect on survival of busulphan treated
mice. Serum collected from mice 2 days
after treatment with cyclophosphamide
(200 mg/kg) was injected into syngeneic
mice lethally treated with busulphan
(40 mg/kg). Table II shows that dialysed
serum injected i.p. on 3 consecutive days
following the busulphan administration
markedly increased the 30-day survival
200
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TABLE II.-Effect of Serum from Cyclophosphamide Treated Animals on the 30-day
Survival of Animals Lethally Treated with Busuiphan (40 mg/kg)
Animals treated with 40 mg/kg
busulphan and:
Normal serum
Normal serum after dialysis
Precipitate from dialysed normal
serum
Serum from animals pretreated with
cyclophosphamide
Serum from animals pretreated with
cyclophosphamide after dialysis
Precipitate from dialysed serum of
animals pretreated with
cyclophosphamide
No serum
Experiment
Exp. A
Normal animals 7 days
recovery
Exp. B
Normal animals
4-day recovery
7-day recovery
Exp. C
Splenectomized animals
7-day recovery
14-day recovery
Exp. D
Normal animals
11-day recovery
14-day recovery
Splenectomized animals
11-day recovery
14-day recovery
30-day survival
0/13 0%
1/25 4%
1/23 4%
5/14 36%
11/24 46%
3/25 12%
Average day of
death of non-
survivors ± S.E.
14-8±0-7
15- 1+0-7
14-6±0-7
14-7±1-0
18-4±0-6
16-4±0 6
1/24 4% 16*0±0-9
40 mg/kg busulphan 40 mg/kg busulphan + dialyp
± normal dialysed serum from cyclophosphami
serum treated animals
0-51±0-06%
4 3±0 9%
8-5±0-6%
0-30±0-05%
0-12±0-04%
0-19±0-05%
0-27±0-06%
0-35±0-07°%
0-52±0- 11 %
0-154-0 05%
5-3±0 6%
6-4±0-5%
0 15±0-04%
0-52±0-09%
0 14±0-05%
0-32+0-08%
0-32±0-08%
0-41±0-09%
Average granulocyte
count per mm3 10
days after busulphan
± S.E.
6094 137
152±26
405± 144
1018±292
2103±430
1160±272
1656± 349
zls on the Femoral
y), Expressed as a
sed 40 mg/kg
de busulphan
alone
1*4±0*14%
6-5±0 6%
9-0±0 8%
0 09+0*03%
0 39±0*09%
0 33±0*07%
0-48±0*09%
0-46±0* 10%
0-65±0*12%
compared with dialysed normal serum.
The peripheral blood granulocyte count 10
days after the busulphan demonstrates
that the animals which received serum
from cyclophosphamide treated animals,
particularly those that received the
dialysed serum, had considerably higher
granulocyte counts than those which
received normal serum, although they
were not much higher than the count in
animals receiving no serum at all.
Effect on CFU.-Table III shows the
CFU concentration in femurs of mice
treated with a lethal dose of busulphan
and with dialysed serum from normal or
cyclophosphamide pretreated animals.
The experiments, performed in both
normal and splenectomized animals
various days after treatment with busul-
phan and serum, show that the serum had
no stimulating effect on CFU recovery,
whether it came from normal animals or
from animals given cyclophosphamide.
Indeed, in many instances animals given
no serum at all have higher CFU levels per
femur than those given serum.
DISCUSSION
The improved survival of mice treated
with busulphan and cyclophosphamide is
greatest when the cyclophosphamide is
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given 1-2 daysbeforethebusulphan. How-
ever, there is still improved survival when
cyclophosphamide is given after the
busulphan, indicating that the improved
survival is not simply a result of the
cyclophosphamide interfering with the
action of busulphan.
Cyclophosphamide has been shown to
enhance the regeneration of transplanted
CFU (Fried and Johnson, 1968; Gregory
et al., 1971) although the mechanism of
this effect remains unclear. Fried et al.
(1973) failed to demonstrate the presence
of a humoral factor in plasma from
animals treated with cyclophosphamide
which could stinmulate CFU regeneration
in irradiated animals. They concluded
that cyclophosphamide may have its
effect at a local level by destroying many
of the bone marrow cells and thus remov-
ing cell-cell contact inhibition.
We, too, have failed to demonstrate a
serum factor capable of restoring CFU
number even though the serum does
contain a factor which will increase blood
granulocyte concentration and improve
survival of lethally treated mice. How-
ever, other workers have reported that
the recovery of stem cells (CFU) has
been influenced by the administration of
various substances. An alpha macro-
globulin prepared from mouse, or rat
serum (Nettesheim, Hanna and Fisher,
1968) and cell-free spleen extracts are
reported to enhance CFU regeneration in
mice given 200 rad (Knospe et al., 1970).
Most recently, fetuin, an alpha macroglo-
bulin extracted from foetal calfserum, has
been shown to enhance CFU regeneration
in sub-lethally irradiated mice (Dons etal.,
1974).
It seems likely therefore that humoral
stimulators of granulopoiesis exist which
restore granulopoiesis after damage by
irradiation or cytotoxic drugs and that
this is not confined to restoration of the
stem cell pool but also enhancement of
differentiation along the granulocytic
pathway. An animal's survival does not
depend on stem cells alone but on the
capacity of these cells to form functional
progeny and the degree of stimulus to do
so. This is borne out by the disparity
between CFU content of the femur and
actual survival ofthe animal after various
cytotoxic treatments seen by other
workers (Hanks and Ainsworth, 1964;
Smith et al., 1966; Yuhas and Storer,
1969; Dunn and Elson, 1970; Dunjic and
Cuvelier, 1973), and this emphasizes the
limitation of predicting haemopoietic
recovery in terms of CFU measurement
only.
An important question arises as to the
relationship between the factor reported
here and CSF, the factor necessary for the
in vitro growth ofgranulocvtic and mono-
cytic colonies. It has been shown that
there is a rapid increase in CSF in the
serum of animals treated with bacterial
endotoxin (Quesenberry et al., 1972). In
our system the action of cyclophospha-
mide on the cells of the intestinal epithe-
lium may have led to a cellular breakdown
and bacterial invasion from the gut flora.
The subsequent bacteriaemia could have
led to high levels of CSF at the time when
serum was collected for analysis.
The presence of high levels of CSF in
the serum 2 days after cyclophosphamide
is unlikely, however, as it has not been
detected under these conditions by Shad-
duck and Nagabhushanam (1971) or by us
(unpublished observations) using the in
vitro colony forming assay (Pluznik and
Sachs, 1965; Bradley and Metcalf, 1966).
Nevertheless, work is in progress to assess
the effects of bacterial endotoxin and
endotoxin treated mouse serum in sparing
animals from busuilphan induced bone
marrow failure. The work started by
Smith, Alderman and Gillespie (1957) and
Hanks and Ainsworth (1964) has made
this an important consideration.
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